HIV-Leishmania infantum co-infection: Humoral and cellular immune responses to the parasite after chemotherapy

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 94, Issue 3, 2000, Pages 328-332

  Moreno, Javier ^a   Cañavate, Carmen ^a   Chamizo, Cristina ^a   Laguna, Fernando ^a   Alvar, Jorge ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CHRIST S COLLEGE   (United Kingdom)

Author keywords

Cellular immunity; Co infection; HIV; Humoral immunity; Immune response; Leishmania infantum; Spain; Transforming growth factor; Tumour necrosis factor

Indexed keywords

ANTIMONY; CD4 ANTIGEN; CD8 ANTIGEN; PARASITE ANTIBODY; PARASITE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; BLOOD LEVEL; CELL STIMULATION; CELLULAR IMMUNITY; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VITRO STUDY; LEISHMANIA INFANTUM; LEISHMANIASIS; LYMPHOCYTE TRANSFORMATION; PHENOTYPE; RELAPSE; SPAIN; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS; LEISHMANIA INFANTUM; LEISHMANIA SP.; PROTOZOA; RNA VIRUSES;

EID: 0034098340     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(00)90345-6     Document Type: Article

References (29)

1. Alvar, J., Cañavate, C., Gutiérrez-Solar, B., Jiménez, M., Laguna, F., López-Vélez, R., Molina R. & Moreno, J. (1997). Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clinical Microbiology Reviews, 10, 298-319.
2. Bañuls, J., Boix, V., Portilla, J. & Silvestre, J. F. (1995). Leishmaniasis as a cause of oral disease in HIV infection. AIDS, 9, 96-98.
3. Barrai, A., Barral-Netto, M., Yong, E. C., Brownell, C. E., Twardzik, D. R. & Reed, S. G. (1993). Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proceedings of the National Academy of Sciences of the USA, 90, 3442-3446.
4. Berhe, N., Wolday, D., Hailu, A., Abraham, Y., Ali, A., GebreMichael, T., Desjeux, P., Sönnerborg, A., Akuffo, H. & Britton, S. (1999). HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS, 13, 1921-1925.
5. Bernier, R., Turco, S. J., Olivier, M. & Tremblay, M. (1995). Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. Journal of Virology, 69, 7282-7285.
6. 2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 434-435.
7. Carvalho, E. M., Teixeira, R. S. & Johnson, W. D. Jr (1981). Cell mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infection and Immunity, 33, 498-502.
8. Cenini, P., Berhe, N., Hailu, A. & Frommei, D. (1994). Mononuclear cell subpopulations in human immunodeficiency virus (HIV)-positive versus HIV-negative patients with visceral leishmaniasis. Journal of Infectious Diseases, 169, 707-708.
9. Coutinho, S. G., Da-Cruz, A. M., Pereira de Oliveira, M., Mendonça, S. C. F., Bertho, A. L. & De Luca, P. M. (1996). CD4+ and CD8+ T cell immune response of immunocompetent and immunocompromised (AIDS) patients with American tegumentary leishmaniasis. Memorias do Instituto Oswaldo Cruz, 91, 381-384.
10. Haldar, J. P., Ghose, S., Saha, K. C. & Ghose, A. C. (1983). Cell-mediated immune response in Indian kala-azar and post kala-azar dermal leishmaniasis. Infection and Immunity, 42, 702-707.
11. Janossy, G., Borthwick, N., Lomnitzer, R., Medina, E., Squire, S. B., Phillips, A. N., Lipman, M., Johnson, M. A., Lee, C. & Bofill, M. (1993). Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45RO+ cells of the CD4 and CD8 lineages. AIDS, 7, 613-624.
12. Jiménez, M. I., Ferrer-Dufol, M., Cañavate, C., GutierrezSolar, B., Molina, R., Laguna, F., Lopez-Velez, R., Cercenado, E., Dauden, J., Blazquez, C., Ladron de Guevara, C., Gomez, J., De la Torre, J., Barros, C., Altes, J., Serra, T. & Alvar, J. (1995) Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain. FEMS Microbiology Letters, 131, 197-204.
13. Kekow, J., Wachsman, W., McCutchan, J. A., Cronin, M., Carson, D. A. & Lotz, M. (1990). Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proceedings of the National Academy of Sciences of the USA, 87, 8321-8325.
14. Kubar, J., Marty, P., Lelievre, A., Quaranta, J. F., Staccini, P., Caroli-Bosc, C. & Le Fichoux, Y. (1998). Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS, 12, 2147-2153.
15. Laguna, F., Garcia Samaniego, J., Soriano, V., Valencia, E., Redondo, C., Alonso, M. J. & Gonzalez-Lahoz, J. M. (1994). Gastrointestinal leishmaniasis in human immunodeficiency virus infected patients: report of five cases and review. Clinical and Infectious Diseases, 19, 48-53.
16. Mary, C., Lamouroux, D., Dunan, S. & Quilici, M. (1992). Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes. American Journal of Tropical Medicine and Hygiene, 47, 764-771.
17. Medrano, F. J., Hernández-Quero, J., Jiménez, E., Pineda, J. A., Rivero, A., Sanchez-Quijano, A., Velez, I. D., Viciana, P., Castillo, R., Reyes, M. J., Carvajal, F., Leal, M. & Lissen, E. (1992). Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain? AIDS, 6, 1499-1503.
18. Medrano, F. J., Rey, C., Leal, M., Cañavate, C., Rubio, A., Sanchez-Quijano, A., Alvar, J. & Lissen, E. (1998a). Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clinical and Experimental Immunology, 114, 403-407.
19. Medrano, F. J., Cañavate, C., Leal, M., Rey, C., Lissen, E. & Alvar, J. (1998b). The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. American Journal of Tropical Medicine and Hygiene, 59, 155-162.
20. Murray, H. W., Oca, M. J., Granger, A. M. & Schreiber, R. D. (1989). Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. Journal of Clinical Investigation, 83, 1253-1257.
21. Murray, H. W., Squires, K. E., Miralles, C. D., Stoeckle, M. Y., Granger, A. M., Granelli-Piperno, A. & Bogdan, C. (1992). Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. Journal of Immunology, 148, 1858-1863.
22. Poli, G., Kinte, A., Justement, J. S., Kehrl, J. H., Bressler, P. & Fauci A. S. (1990). Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proceedings of the National Academy of Sciences of the USA, 87, 782-785.
23. Poli, G., Kinte, A. L., Justement, J. S., Bressler, P., Kehrl, J. H. & Fauci A. S. (1991). Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. Journal of Experimental Medicine, 173, 589-597
24. Preiser, W., Cacopardo, B., Nigro, L., Braner, J., Nunnari, A., Doerr, H. W. & Weber, B. (1996). Immunological findings in HIV-Leishmania coinfection. Intervirology, 39, 285-288.
25. Tremblay, M., Olivier, M. & Bernier, R. (1996). Leishmania and the pathogenesis of HIV infection. Parasitology Today, 12, 257-261.
26. WHO (1994). Report on the consultative meeting on Leishmania/ HIV co-infections. Instituto Superiore di Sanita and the WHO, Rome, Italy.
27. WHO/UNAIDS (1998). Leishmania and HIV in gridlock. Geneva: World Health Organization. WHO/CTD/LEISH/ 98.9 Add. 1, UNAIDS/98.23.
28. Wolday, D., Akuffo, H., Fessahaye, G., Valantine, A. & Britton, S. (1998). Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells. Scandinavian Journal of Immunology, 39, 380-386.
29. Yebra, M., Segovia, J., Manzano, L., Vargas, J., Bernaldo de Quiros, L. & Alvar, J. (1988). Disseminated-to-skinkala-azar and the acquired immunodeficiency syndrome. Annals of Internal Medicine, 108, 490-491.